Brief: Verona Pharma Announces Amended Strategic Financing With Oaktree And OMERS
28/03/2025 11:54
March 28 (Reuters) - Verona Pharma PLC I9SAy.F: VERONA PHARMA ANNOUNCES AMENDED STRATEGIC FINANCING WITH OAKTREE AND OMERS VERONA PHARMA PLC - AMENDS FINANCING AGREEMENTS, INCREASES DEBT FACILITY TO $450 MILLION VERONA PHARMA PLC - HAS ACCESS TO UP TO $200 MILLION UNDER TERM LOAN FACILITY Source text: ID:nGNX566Wjk Further company coverage: [I9SAy.F] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verona Pharma
See all newsBrief: Acquisition Of Verona By Msd Approved By The High Court Of Justice Of England And Wales
Brief: Shareholders Of Verona Pharma Approve Proposed Acquisition By Merck
US corporate debt market returns in force after market holiday
Merck to cut jobs and costs as demand for Gardasil in China remains weak (updated)
Merck to cut jobs and costs as demand for Gardasil in China remains weak